Skip to main content
ADTX
NASDAQ Life Sciences

10% Owner HRT Financial LP Makes Significant Net Purchase in Aditxt, Inc.

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.012
Mkt Cap
$10.118K
52W Low
$0.012
52W High
$53,450.606
52W Position info
2.5% above low
Off High info
100% below high
Rel. Volume info
23× avg
Market data snapshot near publication time

ADTX is trading near its 52-week low of $0.012 (2.5% above the low) on elevated volume (23× avg).

Summary

A 10% owner of Aditxt, Inc. made a net purchase of over $54,000 in common stock, a substantial investment relative to the company's tiny market cap, coinciding with recent positive spin-off news.


Key Events · Ownership and Investor Activity · ADTX

  • Net Insider Purchase

    HRT Financial LP, a 10% owner, made net open market purchases totaling $54,536.68 in Aditxt, Inc. common stock.

  • Substantial Relative Investment

    The net purchase represents a highly material change in ownership for this micro-cap entity, given its extremely small market capitalization.

  • Timing with Strategic News

    These transactions occurred between June 8-10, coinciding with the announcement of Aditxt's subsidiary, Ignite Proteomics, being spun off via a SPAC merger at a $150 million implied equity value.

  • Purchases Above Current Price

    The shares were acquired at prices ranging from $0.019 to $0.049, which are notably higher than the current stock price of $0.0124.


Analysis · ADTX · Life Sciences

HRT Financial LP, a 10% owner, made a net purchase of over $54,000 in Aditxt, Inc. common stock. This transaction is notable given the company's extremely small market capitalization and recent positive news regarding the spin-off of Ignite Proteomics via a SPAC merger. The purchases were made at prices significantly above the current trading price, suggesting conviction despite the company's distressed financial state.

At the time of this filing, ADTX was trading at $0.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.1K. The 52-week trading range was $0.01 to $53,450.61. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADTX - Latest Insights

ADTX
Jul 17, 2026, 12:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0025
Real-time Price: $0.0031 info
Change: +$0.0006 (+24%) info
Market Cap: $3.094M info
ADTX
Jun 24, 2026, 11:36 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.050599
Real-time Price: $0.0031 info
Change: -$0.047499 (-94%) info
Market Cap: $3.094M info
ADTX
Jun 24, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.0406
Real-time Price: $0.0031 info
Change: -$0.0375 (-92%) info
Market Cap: $3.094M info
ADTX
Jun 23, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.0443
Real-time Price: $0.0031 info
Change: -$0.0412 (-93%) info
Market Cap: $3.094M info
ADTX
Jun 23, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0445
Real-time Price: $0.0031 info
Change: -$0.0414 (-93%) info
Market Cap: $3.094M info